In the last completed session, Glenmark Pharmaceuticals Ltd. closed -0.46% with futures open interest moving +3.7%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The option PCR of 0.72 is balanced — no clear directional preference from option writers. Max-pain strike at ₹2,300 sits 5.8% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Glenmark Pharmaceuticals Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Glenmark Pharmaceuticals Ltd. points to a softer setup at the next open.
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 141%
Δ 0.63
θ -6.0
ν 2
|
2060 |
IV 33%
Δ -0.24
θ -1.0
ν 2
|
|
IV 65%
Δ 0.64
θ -2.9
ν 2
|
2080 |
IV 29%
Δ -0.26
θ -0.9
ν 2
|
|
IV 35%
Δ 0.68
θ -1.6
ν 2
|
2100 |
IV 30%
Δ -0.30
θ -1.0
ν 2
|
|
IV 62%
Δ 0.60
θ -2.8
ν 2
|
2120 |
IV 30%
Δ -0.34
θ -1.1
ν 2
|
|
IV 38%
Δ 0.60
θ -1.8
ν 2
|
2140 |
IV 30%
Δ -0.38
θ -1.1
ν 2
|
|
IV 35%
Δ 0.57
θ -1.7
ν 2
|
2160 |
IV 29%
Δ -0.43
θ -1.1
ν 2
|
|
IV 36%
Δ 0.53
θ -1.8
ν 2
|
2180 |
IV 30%
Δ -0.47
θ -1.1
ν 2
|
|
IV 35%
Δ 0.49
θ -1.7
ν 2
|
2200 S |
IV 29%
Δ -0.52
θ -1.0
ν 2
|
|
IV 35%
Δ 0.45
θ -1.7
ν 2
|
2220 |
IV 29%
Δ -0.56
θ -1.0
ν 2
|
|
IV 34%
Δ 0.41
θ -1.6
ν 2
|
2240 |
IV 29%
Δ -0.61
θ -1.0
ν 2
|
|
IV 35%
Δ 0.38
θ -1.6
ν 2
|
2260 |
IV 31%
Δ -0.64
θ -1.0
ν 2
|
|
IV 34%
Δ 0.34
θ -1.5
ν 2
|
2280 |
IV 34%
Δ -0.66
θ -1.1
ν 2
|
|
IV 35%
Δ 0.31
θ -1.5
ν 2
|
2300 MP |
IV 30%
Δ -0.72
θ -0.8
ν 2
|